Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-83,701
Closed -$4.64M 106
2025
Q1
$4.64M Sell
83,701
-47,800
-36% -$2.59M 0.17% 64
2024
Q4
$6.34M Sell
131,501
-43,400
-25% -$2.21M 0.22% 61
2024
Q3
$10.1M Sell
174,901
-35,800
-17% -$1.93M 0.32% 53
2024
Q2
$10.2M Hold
210,701
0.38% 49
2024
Q1
$10.2M Buy
210,701
+39,700
+23% +$1.94M 0.38% 50
2023
Q4
$8.5M Buy
171,001
+54,960
+47% +$2.69M 0.38% 47
2023
Q3
$6.22M Hold
116,041
0.34% 49
2023
Q2
$6.25M Buy
116,041
+93,431
+413% +$5.03M 0.33% 56
2023
Q1
$1.23M Hold
22,610
0.05% 77
2022
Q4
$1.1M Buy
+22,610
New +$992K 0.05% 69

Other funds holding SNY

Aaron Cowen's SNY Position: Q2 2025 in Review

Aaron Cowen sold out of Sanofi (SNY) in Q2 2025, closing a stake of 83,701 shares — an estimated $4.64M sold.

Aaron Cowen first reported a position in SNY in Q4 2022 and held it in 10 quarters. The position peaked at $10.2M in Q1 2024. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Aaron Cowen reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Aaron Cowen sold 83,701 Sanofi shares in Q2 2025, an estimated $4.64M.
  • Aaron Cowen first reported a position in Sanofi in Q4 2022 and held it in 10 quarters.
  • Aaron Cowen's Sanofi position peaked at $10.2M in Q1 2024.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.